glp-1 heart rate increase and health behavior responses to receptor agonists: a 12-wk study using wearable technology and causal inference | American Journal of Physiology-Heart and Circulatory Physiology What GLP-1s are Really Doing
Description
[DOI] [Google Scholar] 40.McGarry A., Rosanbalm S., Leinonen M., Olanow C.W., To D., Bell A., Lee D., Chang J., Dubow J., Dhall R., et al
Mice homozygous for a dominant negative Pax6 mutation (SEYNeu) have repressed Gcg expression in enteroendocrine cells in the small and large bowel and absence of immunoreactive GLP-1 and GLP-2 [109]
In other words: The evidence supporting GLP-1 therapy assumes clinical oversightnot guesswork
The effect varied depending on the dose and duration of action
This makes semaglutide an effective option for not only managing type 2 diabetes but also supporting significant weight loss
